Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this clinical study is to learn more about the safety and effectiveness of the study drugs, KITE-363 and KITE-753, in participants with relapsed and/or refractory B-cell lymphoma.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Chorowanie na nawracającego lub opornego chłoniaka z komórek B.
- •Posiadanie przynajmniej jednej widocznej zmiany nowotworowej.
- •Dobre funkcjonowanie narządów i szpiku kostnego.
✗ Disqualifies
- •Wcześniejsze leczenie terapią genetycznie zmodyfikowanych komórek T (w tym CAR-T).
- •Inne nowotwory w przeszłości (z pewnymi wyjątkami).
- •Przeszczepienie komórek macierzystych od obcego dawcy.
- •Przeszczepienie własnych komórek macierzystych w ciągu ostatnich 6 tygodni.
- •Niekontrolowane infekcje (grzybicze, bakteryjne, wirusowe).
- •Znana infekcja HIV, WZW B lub WZW C (chyba że wirus nie jest wykrywalny).
- •Podejrzenie lub potwierdzenie chłoniaka w mózgu lub rdzeniu kręgowym.
- •Problemy z sercem w ciągu ostatnich 6 miesięcy.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- June 29, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (26)
Banner MD Anderson Cancer Center
Gilbert, United States
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Duarte, United States
Stanford Cancer Institute
Stanford, United States
Moffitt Cancer Center
Tampa, United States
Northside Hospital
Atlanta, United States
Midwestern Regional Medical Center, Inc.City of Hope Chicago
Park Ridge, United States
Norton Cancer Institute, St. Matthews Campus
Shelbyville, United States
University of MD, Greenebaum Comprehensive Cancer Center
Baltimore, United States
Hackensack University Medical Center
Hackensack, United States
Columbia University Irving Medical Center
New York, United States
University of Rochester Medical Center
Rochester, United States
The Ohio State University Wexner Medical Center - James Cancer Hospital
Columbus, United States
Tennessee Oncology, PLLC - Investigational Drug Services
Nashville, United States
Vanderbilt University
Nashville, United States
St. David's Medical Center
Austin, United States
The University of Texas, MD Anderson Cancer Center
Houston, United States
Virginia Oncology Associates
Norfolk, United States
Royal North Shore Hospital
St Leonards, Australia
Concord Repatriation General Hospital
Sydney, Australia
Royal Adelaide Hospital
Adelaide, Australia
Epworth Healthcare
East Melbourne, Australia
Jewish General Hospital
Montreal, Canada
McGill University Health Center
Montreal, Canada
Universitatsklinikum Wurzburg
Würzburg, Germany
Academisch Medisch Centrum
Amsterdam, Netherlands
King's College Hospital
London, United Kingdom
Trial contact
Medical Information
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.